Pediatrix Medical Group I... (MD)
NYSE: MD
· Real-Time Price · USD
17.07
0.06 (0.35%)
At close: Sep 05, 2025, 3:59 PM
17.07
-0.03%
After-hours: Sep 05, 2025, 05:29 PM EDT
Pediatrix Medical Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Health Care, Patient Service Revenue | 397.41M | 389.38M | 430.25M | 438.68M | 432.85M | 421.83M | 425.48M | 437.32M | 430.38M | 423.18M | 443.19M | 421.08M | 418.51M | 406.04M | 414.46M | 432.85M | 412.95M | 381.06M | 348.02M | 382.94M | 428.47M | 734.39M | 791.94M | 784.93M | 765.52M | 749.59M | 789.73M |
| Health Care, Patient Service Revenue Growth | +2.06% | -9.50% | -1.92% | +1.35% | +2.61% | -0.86% | -2.71% | +1.61% | +1.70% | -4.51% | +5.25% | +0.62% | +3.07% | -2.03% | -4.25% | +4.82% | +8.37% | +9.50% | -9.12% | -10.63% | -41.66% | -7.27% | +0.89% | +2.54% | +2.13% | -5.08% | n/a |
| Hospitals Contracts Revenue | 68.22M | 65.18M | 71.56M | 72.41M | 70.91M | 71.8M | 71.39M | 68.71M | 69.58M | 65.99M | 66.51M | 67.42M | 65.48M | 63.53M | 64.56M | 59.49M | 58.9M | 57.07M | 63.66M | 61.19M | 65.14M | 104.59M | 107.61M | 97.75M | 96.74M | 94.72M | 89.5M |
| Hospitals Contracts Revenue Growth | +4.66% | -8.90% | -1.18% | +2.12% | -1.24% | +0.58% | +3.90% | -1.25% | +5.45% | -0.78% | -1.35% | +2.96% | +3.08% | -1.60% | +8.52% | +1.00% | +3.22% | -10.35% | +4.04% | -6.07% | -37.72% | -2.80% | +10.09% | +1.04% | +2.13% | +5.83% | n/a |
| Product and Service, Other Revenue | 3.21M | 3.8M | 558K | 70K | 536K | 1.47M | n/a | 579K | 609K | 1.83M | 4.15M | 1.41M | 2.04M | 12.67M | 19.51M | 604K | 1.1M | 8.62M | 4.96M | 16.51M | 15.59M | 6.94M | 5.83M | 5.99M | 6.04M | 6.88M | n/a |
| Product and Service, Other Revenue Growth | -15.46% | +580.47% | +697.14% | -86.94% | -63.46% | n/a | -100.00% | -4.93% | -66.81% | -55.75% | +193.70% | -30.95% | -83.86% | -35.08% | +3130.63% | -45.34% | -87.19% | +73.98% | -69.98% | +5.91% | +124.80% | +19.01% | -2.75% | -0.83% | -12.13% | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 55.71M | 58.6M | 63.55M | 58.12M | 56.56M | 60.2M | 53.06M | 57.41M | 58.01M | 59.06M | 51.06M | 57.89M | 61.16M | 61.29M | 58.98M | 66.89M | 70.97M | 66.52M | 54.67M | 66.35M | 77.67M | 105.23M | 96.93M | 102.36M | 103.54M | 101.82M | 112.79M | 102.91M | 107.91M | 108.78M | 108.89M | 101.43M | 103.02M | 103.77M | 97.05M | 93.46M | 92.12M | 89.95M | 85.39M | 80.19M | 72.4M | 67.94M |
| Selling, General, and Administrative Revenue Growth | -4.93% | -7.79% | +9.35% | +2.75% | -6.04% | +13.44% | -7.56% | -1.05% | -1.77% | +15.67% | -11.80% | -5.36% | -0.20% | +3.91% | -11.83% | -5.74% | +6.69% | +21.67% | -17.60% | -14.58% | -26.19% | +8.57% | -5.31% | -1.14% | +1.69% | -9.72% | +9.60% | -4.64% | -0.80% | -0.11% | +7.36% | -1.54% | -0.72% | +6.92% | +3.84% | +1.46% | +2.41% | +5.34% | +6.49% | +10.75% | +6.57% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |